Showing results (21-30 of 262,841) with videos related to

Sort By:
Pageof 26,285
Cancer Cell|October 12, 2016
SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of OriginGiustina Ferone, Ji-Ying Song, Kate D Sutherland, et al.
Surgical Endoscopy|April 4, 2013
Biologic meshes are not superior to synthetic meshes in ventral hernia repair: an experimental study with long-term follow-up evaluationM Ditzel, E B Deerenberg, N Grotenhuis, et al.
Cell|December 1, 2009
RNF12 is an X-Encoded dose-dependent activator of X chromosome inactivationIris Jonkers, Tahsin Stefan Barakat, Eskeatnaf Mulugeta Achame, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 2, 2021
[Treatment of non-small cell lung cancer]J S Hopstaken, J C de Ruiter, J N A van Diessen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2018
Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion-Positive Advanced NSCLCBianca van Veggel, Adrianus J de Langen, Sayed M S Hashemi, et al.
Oncoimmunology|August 27, 2024
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL productsSuzanne M Castenmiller, Nandhini Kanagasabesan, Aurélie Guislain, et al.
The Lancet. Respiratory Medicine|January 21, 2019
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trialMaria J Disselhorst, Josine Quispel-Janssen, Ferry Lalezari, et al.
British Journal of Cancer|August 1, 2018
Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatmentAdrianus J de Langen, M Jebbink, Sayed M S Hashemi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responsesBianca van Veggel, Adrianus J de Langen, Sayed Hashemi, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastasesPeter H Wessels, Sten Cornellisen, Kim Monkhorst, et al.
Pageof 26,285